People taking immunosuppressive drugs to prevent organ transplant rejection or to treat inflammatory or autoimmune diseases do not fare worse than others on average when they are hospitalized with COVID-19, according to a new study.
Click here for original story, COVID-19 outcomes for patients on immunosuppressive drugs on par with non-immunosuppressed patients, study finds
Source: ScienceDaily